prescribing guide semaglutide tirzepatide vs. for Obesity Prescribing Information | Ozempic® (semaglutide)

Semaglutide remains a highly effective single-receptor agonist with robust real-world data and a longer safety track record

Clinical trials show an average loss of 5% to 10% of body weight by month three on semaglutide, regardless of whether dosing is standard or microdosed

Lack of sleep can disrupt hormones, leptin, and ghrelin, that regulate hunger and increase appetite and cravings

Tesamorelin is most effective for adults who: Have excess visceral belly fat that does not respond to diet or exercise Are over 30 and noticing body composition changes despite a healthy lifestyle Want to preserve muscle while losing fat (unlike most weight loss approaches) Are looking for a non-surgical, medically supervised option Have already explored conventional approaches without satisfying results A thorough health assessment is required before starting